Wall Street analysts predict that Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) will post sales of $157.27 million for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Sabra Healthcare REIT’s earnings, with the lowest sales estimate coming in at $150.27 million and the highest estimate coming in at $162.31 million. Sabra Healthcare REIT reported sales of $61.79 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 154.5%. The firm is scheduled to report its next earnings results on Wednesday, February 28th.

According to Zacks, analysts expect that Sabra Healthcare REIT will report full-year sales of $157.27 million for the current financial year, with estimates ranging from $381.38 million to $401.49 million. For the next year, analysts expect that the firm will post sales of $619.67 million per share, with estimates ranging from $609.57 million to $635.90 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Sabra Healthcare REIT.

Several research analysts recently weighed in on the stock. Cantor Fitzgerald reissued a “buy” rating and set a $30.00 price objective on shares of Sabra Healthcare REIT in a research note on Friday, September 8th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Friday, November 3rd. SunTrust Banks reaffirmed a “buy” rating and issued a $30.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, October 9th. Capital One Financial began coverage on shares of Sabra Healthcare REIT in a research report on Monday, September 25th. They issued an “equal weight” rating and a $24.00 price objective on the stock. Finally, TheStreet lowered shares of Sabra Healthcare REIT from a “b-” rating to a “c” rating in a research report on Friday, November 3rd. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. Sabra Healthcare REIT presently has an average rating of “Hold” and an average target price of $24.40.

Shares of Sabra Healthcare REIT (NASDAQ SBRA) traded down $0.18 during trading hours on Thursday, hitting $18.82. 1,219,800 shares of the stock traded hands, compared to its average volume of 1,584,088. Sabra Healthcare REIT has a 12 month low of $18.48 and a 12 month high of $29.10. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market cap of $3,386.41, a PE ratio of 8.33, a price-to-earnings-growth ratio of 2.47 and a beta of 0.92.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th were issued a $0.07 dividend. The ex-dividend date was Tuesday, November 14th. This represents a $0.28 annualized dividend and a dividend yield of 1.49%. Sabra Healthcare REIT’s dividend payout ratio is currently 221.28%.

In other Sabra Healthcare REIT news, Director Milton J. Walters sold 4,615 shares of the company’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total value of $88,515.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.60% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Sabra Healthcare REIT by 9.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock valued at $100,000 after acquiring an additional 352 shares during the period. Daiwa Securities Group Inc. boosted its position in shares of Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock valued at $142,000 after acquiring an additional 800 shares during the period. FNY Partners Fund LP bought a new stake in shares of Sabra Healthcare REIT in the third quarter valued at about $155,000. Riverhead Capital Management LLC boosted its position in shares of Sabra Healthcare REIT by 96.0% in the second quarter. Riverhead Capital Management LLC now owns 6,861 shares of the real estate investment trust’s stock valued at $165,000 after acquiring an additional 3,361 shares during the period. Finally, Flinton Capital Management LLC boosted its position in shares of Sabra Healthcare REIT by 96.1% in the second quarter. Flinton Capital Management LLC now owns 6,868 shares of the real estate investment trust’s stock valued at $165,000 after acquiring an additional 3,366 shares during the period. Hedge funds and other institutional investors own 85.51% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Analysts Expect Sabra Healthcare REIT, Inc. (SBRA) Will Announce Quarterly Sales of $157.27 Million” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/07/analysts-expect-sabra-healthcare-reit-inc-sbra-will-announce-quarterly-sales-of-157-27-million.html.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get a free copy of the Zacks research report on Sabra Healthcare REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.